Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−1.21 EUR
−1.48 M EUR
447.24 M EUR
55.23 M
About INARI MEDICAL INC
Sector
Industry
CEO
Andrew J. Hykes
Website
Founded
2011
FIGI
Inari Medical is a commercial-stage medical device company focused on developing products to treat and transform the lives of patients suffering from venous diseases. They are focused on treating venous thromboembolism and improving the quality of life of patients suffering from this disease by safely and effectively removing blood clots. It has developed two minimally-invasive, novel catheter-based mechanical thrombectomy devices that are designed to remove large clots from large vessels and eliminate the need for thrombolytic drugs. The ClotTriever system is 510(k)-cleared by the FDA for thrombectomy in the peripheral vessels and is used to treat patients suffering from deep vein thrombosis. The FlowTriever system is 510(k)-cleared by the FDA for the treatment of pulmonary embolism.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of IM7 is 76.50 EUR — it has decreased by −1.29% in the past 24 hours. Watch INARI MEDICAL INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange INARI MEDICAL INC stocks are traded under the ticker IM7.
IM7 stock has risen by 0.66% compared to the previous week, the month change is a 0.66% rise, over the last year INARI MEDICAL INC has showed a 101.32% increase.
We've gathered analysts' opinions on INARI MEDICAL INC future price: according to them, IM7 price has a max estimate of 76.19 EUR and a min estimate of 76.19 EUR. Watch IM7 chart and read a more detailed INARI MEDICAL INC stock forecast: see what analysts think of INARI MEDICAL INC and suggest that you do with its stocks.
IM7 stock is 2.65% volatile and has beta coefficient of −0.46. Track INARI MEDICAL INC stock price on the chart and check out the list of the most volatile stocks — is INARI MEDICAL INC there?
Today INARI MEDICAL INC has the market capitalization of 4.46 B, it has increased by 0.37% over the last week.
Yes, you can track INARI MEDICAL INC financials in yearly and quarterly reports right on TradingView.
INARI MEDICAL INC is going to release the next earnings report on Mar 4, 2025. Keep track of upcoming events with our Earnings Calendar.
IM7 earnings for the last quarter are −0.08 EUR per share, whereas the estimation was −0.10 EUR resulting in a 27.69% surprise. The estimated earnings for the next quarter are −0.11 EUR per share. See more details about INARI MEDICAL INC earnings.
INARI MEDICAL INC revenue for the last quarter amounts to 137.77 M EUR, despite the estimated figure of 135.34 M EUR. In the next quarter, revenue is expected to reach 155.75 M EUR.
IM7 net income for the last quarter is −16.50 M EUR, while the quarter before that showed −29.27 M EUR of net income which accounts for 43.63% change. Track more INARI MEDICAL INC financial stats to get the full picture.
No, IM7 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Feb 23, 2025, the company has 1.30 K employees. See our rating of the largest employees — is INARI MEDICAL INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INARI MEDICAL INC EBITDA is −13.60 M EUR, and current EBITDA margin is 1.44%. See more stats in INARI MEDICAL INC financial statements.
Like other stocks, IM7 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INARI MEDICAL INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INARI MEDICAL INC technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INARI MEDICAL INC stock shows the strong buy signal. See more of INARI MEDICAL INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.